Related references
Note: Only part of the references are listed.Effect of C-reactive protein reduction on paroxysmal atrial fibrillation
J Dernellis et al.
AMERICAN HEART JOURNAL (2005)
Animal model - Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death
HD Xiao et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation
MJ Mihm et al.
CIRCULATION (2001)
The gap-junctional protein connexin40 is elevated in patients susceptible to postoperative atrial fibrillation
E Dupont et al.
CIRCULATION (2001)
Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure - Insights from the Randomized Aldactone Evaluation Study (RALES)
F Zannad et al.
CIRCULATION (2000)
Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation
H Nakashima et al.
CIRCULATION (2000)
Atrial but not ventricular fibrosis in mice expressing a mutant transforming growth Factor-β1 transgene in the heart
H Nakajima et al.
CIRCULATION RESEARCH (2000)
Important role of local angiotensin II activity mediated via type 1 receptor in the pathogenesis of cardiovascular inflammatory changes induced by chronic blockade of nitric oxide synthesis in rats
M Usui et al.
CIRCULATION (2000)
Share Paper
